Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer-Reference-Cited by-同舟云学术

Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer

Published:2019-01-03 Issue:1 Volume:2019 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Stern Anat¹,Carrara Elena²,Bitterman Roni¹,Yahav Dafna³,Leibovici Leonard³,Paul Mical¹

Affiliation:

1. Rambam Health Care Campus; Division of Infectious Diseases; Ha-aliya 8 St Haifa Israel 33705

2. Policlinico San Matteo Hospital; Infectious Diseases; University of Pavia Pavia Lombardy Italy 27100

3. Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012184.pub2/epdf/full

Reference64 articles.

1. Aguilar-Guisado M Espigado I Martín-Peña A Gudiol C Falantes J Vázquez L Empirical antimicrobial therapy withdrawal after 72 hours of apyrexia in hematological patients with febrile neutropenia is safe and reduce unnecessary antibotic exposure: final results of randomized clinical trial “How Long” ECCMID proceeding 2017 April

2. A study of antibiotic therapy in fever of unknown origin in neutropenic cancer patients;Björnsson;Medical and Pediatric Oncology,1977

3. Randomized placebo-controlled trial of oral antibiotics in pediatric oncology patients at low-risk with fever and neutropenia;Klaassen;Journal of Pediatric Hematology/Oncology,2000

4. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer;Pizzo PA;American Journal of Medicine,1979

5. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia;Pizzo PA;American Journal of Medicine,1982

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncology Intensive Care Units: Distinguishing Features and Clinical Considerations;Journal of Intensive Care Medicine;2024-08-23

2. Safety of empirical antibiotic therapy discontinuing for fever of unknown origin during high-risk neutropenia in children;Journal of Infection;2024-06

3. Study Design and Methodology of Antibiotic Duration in Hematological Patients With Pseudomonas aeruginosa Bloodstream Infection;Clinical Infectious Diseases;2024-05-29

4. “Better at home”: Mixed methods report of intricacies in pediatric febrile neutropenia management;Cancer Medicine;2024-03

5. Safety of Procalcitonin Guided Early Discontinuation of Antibiotic Therapy among Children Receiving Cancer Chemotherapy and Having Low-Risk Febrile Neutropenia: A Randomized Feasibility Trial (ProFenC Study);Pediatric Hematology and Oncology;2023-09-01